Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston
6
×
boston blog main
boston top stories
6
×
clinical trials
life sciences
national blog main
fda
national top stories
new york blog main
san diego blog main
dyne therapeutics
ipo
myotonic dystrophy type 1
rare disease drugs
renaissance capital
san diego top stories
san francisco blog main
480 biomedical
ally bridge group
antibiotics
arsenal medical
arvinas
astellas pharma
astrazeneca
atlas venture
audentes therapeutics
avidity biosciences
big data analytics
biotech ipos
blackrock
bluebird bio
bob langer
boulder/denver
boulder/denver blog main
boulder/denver top stories
cancer
carbapenem-resistant enterobacteriaceae
casdin capital
celgene
What
ipo
6
×
company
medicines
million
drug
genetic
new
raised
therapeutics
biotech
biotechs
brings
developing
diseases
dyne
ipos
muscle
raises
rare
tests
way
ago
analysis
based
begin
bio
biosciences
bio’s
bring
bubbles
cells
chose
class
clinical
close
codiak
considering
data
debut
develop
Language
unset
Current search:
boston
×
ipo
×
" boston top stories "
×
@xconomy.com
3 years ago
Codiak Bio’s IPO Brings In $82M as Exosome Clinical Trials Begin
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
5 years ago
Six Life Science Firms Close Q3 with an IPO, More Are on the Way